Gavin MacBeath

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Modal Labs has secured $750 million in Series D funding at a $15.75 billion valuation, marking a nearly 239% valuation surge in five months as demand for AI inference, GPU cloud infrastructure and autonomous coding agents accelerates, pushing the company's annualized run rate beyond $1 billion. Representative image.

Modal valuation jumps 239% as AI infrastructure demand drives $750m Series D

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Patient volumes rose 10% at Montrose Regional Health, so why are 77 positions disappearing?

Royal Mail wants 2,500 fewer support roles. Can it afford a frontline retention problem too?

TScan Therapeutics is cutting 75% of its workforce after starting Phase 3. What changed?

TScan Therapeutics has cut approximately three-quarters of its workforce, paused further enrolment in its Phase 3 ALLOHA-2 trial and removed both its chief financial officer and chief medical officer as it redirects its remaining capital toward in vivo cell therapy.

byPallavi Madhiraju

September 3, 2026

TScan, Novartis to develop T cell receptor therapies for solid tumors

TScan Therapeutics has partnered with Swiss pharma giant Novartis to discover and develop novel TCR-engineered T cell receptor…

bypharmanewsdaily

April 22, 2020

The Latest

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Patient volumes rose 10% at Montrose Regional Health, so why are 77 positions disappearing?

Royal Mail wants 2,500 fewer support roles. Can it afford a frontline retention problem too?

TScan Therapeutics is cutting 75% of its workforce after starting Phase 3. What changed?

TScan, Novartis to develop T cell receptor therapies for solid tumors

Salad and Go is coming back after bankruptcy, but competitors bought most of its old drive-thru network

Patient volumes rose 10% at Montrose Regional Health, so why are 77 positions disappearing?

Royal Mail wants 2,500 fewer support roles. Can it afford a frontline retention problem too?

Emergent’s Q2 adjusted EBITDA hit $96.5m, so what does its CFO successor inherit?

Rath AG nearly erased its first-half loss. Why is it now closing two European factories?

Pernod Ricard India sales jump 19% as U.S. falls 10% and China drops 25%

Ahold Delhaize cyber outage keeps grocery e-commerce offline as AD shares recover